Literature DB >> 998262

Identification of paramyxovirus-specific haemolysis-inhibiting antibodies separate from haemagglutinating-inhibiting and neuraminidase-inhibiting antibodies. 2. NDV and mumps virus haemolysis-inhibiting antibodies.

C Orvell.   

Abstract

Egg-grown Newcastle disease (NDV) and mumps virus were used for preparation of rabbit hyperimmune sera against purified whole virus and projectionless virus particles. These sera and convalescent sera after natural NDV and mumps infections in chickens and human subjects, respectively, were studied in haemolysis-inhibition (HLI), haemagglutination-inhibition (HI) and neuraminidase-inhibition (NI) tests both before and after absorption with Tween 80-ether (TE) treated virus preparations. In addition, neutralization tests using the different sera were carried out. HI and NI antibodies and the major population of neutralizing antibodies in convalescent sera were removed by absorption with TE treated virus material without changing the titre of non-HI HLI antibodies. Rabbit hyperimmune sera directed against projectionless virus particles exhibited HLI antibody titres in marked excess of HI and NI antibody titres, whereas this was not found in sera against whole virus. Absorption with TE treated virus material resulted in removal of all demonstrable antibody activities in sera against whole virus. The corresponding absorption of sera against projectionless particles eliminated HI antibodies without changing the titre of non-Hi HLI antibodies. In rabbit hyperimmune sera, HI antibodies were of primary importance in neutralization tests. After addition of anti-gamma globulin to the test, an efficient neutralization was observed if mumps non-HI HLI antibodies were used whereas this was not found if NDV non-HI HLI antibodies were used.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 998262

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  5 in total

1.  Enzyme-linked immunosorbent assay compared with neutralization tests for evaluation of live mumps vaccines.

Authors:  H Sakata; M Hishiyama; A Sugiura
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

2.  Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus.

Authors:  Y Umino; T Kohama; M Kohase; A Sugiura; H D Klenk; R Rott
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

3.  Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study.

Authors:  Jeremy Seto; Liang Qiao; Carolin A Guenzel; Sa Xiao; Megan L Shaw; Fernand Hayot; Stuart C Sealfon
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

4.  New tests for characterization of mumps virus antibodies: hemolysis inhibition, single radial immunodiffusion with immobilized virions, and mixed hemadsorption.

Authors:  E Norrby; M Grandien; C Orvell
Journal:  J Clin Microbiol       Date:  1977-03       Impact factor: 5.948

5.  Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein.

Authors:  R M Iorio; M A Bratt
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.